A Prospective Study on Risk Factors for Olfactory Dysfunction in Aging.
Epidemiology
Longitudinal design
Olfactory impairment
Sensory
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
14 02 2020
14 02 2020
Historique:
received:
01
07
2019
pubmed:
15
11
2019
medline:
21
11
2020
entrez:
15
11
2019
Statut:
ppublish
Résumé
Olfactory dysfunction (OD) refers to a reduced or absent ability to smell. OD negatively impacts health and quality of life and its prevalence increases with advancing age. Since OD may be an early marker of dementia and impending death, more knowledge regarding risk factors of OD in aging is warranted. The objective was therefore to explore longitudinally which demographic, genetic, clinical, lifestyle, and cognitive factors predict the development of OD. The study included participants aged 60-90 years from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K), who did not have OD at baseline and were reassessed with an odor identification task at a 6-year follow-up (n = 1,004). Risk factors of OD were assessed with multivariable logistic regression analyses. The percentage of incident OD cases was 14.2% over 6 years in the total sample and this number increased monotonically with age. Increasing age, carrying the ε4 allele of the APOE gene, atrial fibrillation, cerebrovascular disease, and current smoking were found to be risk factors for the development of OD, whereas better olfactory identification and verbal episodic memory proficiency at baseline were identified as protective factors. In addition to nonmodifiable factors (age and genetic risk), several modifiable risk factors of OD were identified. This suggests that it might be possible to reduce OD incidence through the management of vascular risk factors and maintenance of a healthy lifestyle.
Sections du résumé
BACKGROUND
Olfactory dysfunction (OD) refers to a reduced or absent ability to smell. OD negatively impacts health and quality of life and its prevalence increases with advancing age. Since OD may be an early marker of dementia and impending death, more knowledge regarding risk factors of OD in aging is warranted. The objective was therefore to explore longitudinally which demographic, genetic, clinical, lifestyle, and cognitive factors predict the development of OD.
METHODS
The study included participants aged 60-90 years from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K), who did not have OD at baseline and were reassessed with an odor identification task at a 6-year follow-up (n = 1,004). Risk factors of OD were assessed with multivariable logistic regression analyses.
RESULTS
The percentage of incident OD cases was 14.2% over 6 years in the total sample and this number increased monotonically with age. Increasing age, carrying the ε4 allele of the APOE gene, atrial fibrillation, cerebrovascular disease, and current smoking were found to be risk factors for the development of OD, whereas better olfactory identification and verbal episodic memory proficiency at baseline were identified as protective factors.
CONCLUSIONS
In addition to nonmodifiable factors (age and genetic risk), several modifiable risk factors of OD were identified. This suggests that it might be possible to reduce OD incidence through the management of vascular risk factors and maintenance of a healthy lifestyle.
Identifiants
pubmed: 31724031
pii: 5625500
doi: 10.1093/gerona/glz265
pmc: PMC7021638
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-610Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America.
Références
J Am Geriatr Soc. 2017 Jun;65(6):1238-1243
pubmed: 28326534
Alcohol Clin Exp Res. 2003 Mar;27(3):432-9
pubmed: 12658108
BMC Neurol. 2015 Oct 12;15:199
pubmed: 26459234
Nat Rev Neurol. 2013 Feb;9(2):106-18
pubmed: 23296339
Circ Res. 2017 Feb 3;120(3):472-495
pubmed: 28154098
Ann Otol Rhinol Laryngol. 2001 Oct;110(10):976-81
pubmed: 11642433
Circulation. 2017 Aug 8;136(6):583-596
pubmed: 28784826
J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):669-675
pubmed: 27449140
Ann Intern Med. 2019 May 21;170(10):673-681
pubmed: 31035288
J Aging Health. 2010 Mar;22(2):154-68
pubmed: 20133956
Geriatr Gerontol Int. 2014 Jan;14(1):23-31
pubmed: 23682773
Scand J Rheumatol. 1993;22(1):14-9
pubmed: 8434241
Front Aging Neurosci. 2010 Jun 07;2:24
pubmed: 20589104
Annu Rev Psychol. 2019 Jan 4;70:219-243
pubmed: 29949727
J Affect Disord. 2006 Feb;90(2-3):187-91
pubmed: 16376994
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Sci Rep. 2016 Apr 25;6:25026
pubmed: 27109506
Chem Senses. 2014 Mar;39(3):185-94
pubmed: 24429163
J Comp Neurol. 2003 Feb 3;456(2):176-83
pubmed: 12509874
Psychol Aging. 2013 Mar;28(1):262-74
pubmed: 23276211
PLoS One. 2014 Oct 01;9(10):e107541
pubmed: 25271633
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1435-41
pubmed: 26253908
JAMA Otolaryngol Head Neck Surg. 2013 Oct;139(10):1061-6
pubmed: 24135745
Laryngoscope. 2017 Aug;127(8):1753-1761
pubmed: 28561327
Neurobiol Aging. 2016 May;41:173-186
pubmed: 27103530
Postgrad Med J. 2006 Apr;82(966):239-41
pubmed: 16597809
Behav Neurol. 2015;2015:675635
pubmed: 26199458
J Gerontol A Biol Sci Med Sci. 2017 Aug 1;72(8):1072-1079
pubmed: 28444135
Front Psychol. 2014 Feb 07;5:20
pubmed: 24570664
Sci Rep. 2017 Apr 28;7(1):1286
pubmed: 28455505
Sci Rep. 2016 Jun 23;6:28635
pubmed: 27334559
Neuroepidemiology. 2006;26(2):61-7
pubmed: 16352908
JAMA. 2002 Nov 13;288(18):2307-12
pubmed: 12425708
Front Psychol. 2018 Jul 06;9:1138
pubmed: 30034354
Chem Senses. 2004 Jul;29(6):547-54
pubmed: 15269128
Curr Allergy Asthma Rep. 2018 Jun 15;18(8):42
pubmed: 29904888
J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):879-84
pubmed: 25182599
Laryngoscope. 2011 Apr;121(4):873-8
pubmed: 21298645
Neurology. 2019 Feb 12;92(7):e700-e709
pubmed: 30651382
Cephalalgia. 1988;8 Suppl 7:1-96
pubmed: 3048700
Maturitas. 2014 Apr;77(4):305-10
pubmed: 24495787
J Gerontol A Biol Sci Med Sci. 2017 Aug 1;72(8):1067-1071
pubmed: 27811155
Neurobiol Aging. 2010 Apr;31(4):567-77
pubmed: 18619712
Int Forum Allergy Rhinol. 2019 Sep;9(9):977-985
pubmed: 31365791
Epidemiology. 2005 Nov;16(6):766-71
pubmed: 16222166
J Intern Med. 2018 May;283(5):489-499
pubmed: 29415323
J Int Neuropsychol Soc. 2014 Feb;20(2):209-17
pubmed: 24451436